Robert Alexander Ingram - Net Worth and Insider Trading

Robert Alexander Ingram Net Worth

The estimated net worth of Robert Alexander Ingram is at least $14 Million dollars as of 2024-11-06. Robert Alexander Ingram is the Director of Edwards Lifesciences Corp and owns about 183,246 shares of Edwards Lifesciences Corp (EW) stock worth over $12 Million. Robert Alexander Ingram is the Director of Regeneron Pharmaceuticals Inc and owns about 1,500 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $1 Million. Robert Alexander Ingram is also the Director of Wolfspeed Inc and owns about 48,846 shares of Wolfspeed Inc (WOLF) stock worth over $628,648. Besides these, Robert Alexander Ingram also holds BioCryst Pharmaceuticals Inc (BCRX) , Black Diamond Therapeutics Inc (BDTX) , NVN Liquidation Inc (NOVNQ) , Allergan PLC (AGN) , Lowe's Companies Inc (LOW) , Bausch Health Companies Inc (BHC) . Details can be seen in Robert Alexander Ingram's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Alexander Ingram has not made any transactions after 2020-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Alexander Ingram

To

Robert Alexander Ingram Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Alexander Ingram owns 12 companies in total, including Black Diamond Therapeutics Inc (BDTX) , BioCryst Pharmaceuticals Inc (BCRX) , and NVN Liquidation Inc (NOVNQ) among others .

Click here to see the complete history of Robert Alexander Ingram’s form 4 insider trades.

Insider Ownership Summary of Robert Alexander Ingram

Ticker Comapny Transaction Date Type of Owner
BDTX Black Diamond Therapeutics Inc 2020-09-30 director
BCRX BioCryst Pharmaceuticals Inc 2019-11-18 director
NOVNQ NVN Liquidation Inc 2019-05-22 director
LIMIT LIMIT 2018-10-17 10 percent owner
LIMIT LIMIT 2015-12-01 director
LIMIT LIMIT 2017-05-22 10 percent owner
LIMIT LIMIT 2011-02-28 director
LIMIT LIMIT 2016-06-01 10 percent owner
LIMIT LIMIT 2015-05-27 director
LIMIT LIMIT 2014-07-31 director
LIMIT LIMIT 2010-05-27 director
LIMIT LIMIT 2006-03-31 director

Robert Alexander Ingram Latest Holdings Summary

Robert Alexander Ingram currently owns a total of 9 stocks. Among these stocks, Robert Alexander Ingram owns 183,246 shares of Edwards Lifesciences Corp (EW) as of July 31, 2014, with a value of $12 Million and a weighting of 84.58%. Robert Alexander Ingram owns 1,500 shares of Regeneron Pharmaceuticals Inc (REGN) as of May 27, 2015, with a value of $1 Million and a weighting of 8.61%. Robert Alexander Ingram also owns 48,846 shares of Wolfspeed Inc (WOLF) as of December 1, 2015, with a value of $628,648 and a weighting of 4.35%. The other 6 stocks BioCryst Pharmaceuticals Inc (BCRX) , Black Diamond Therapeutics Inc (BDTX) , NVN Liquidation Inc (NOVNQ) , Allergan PLC (AGN) , Lowe's Companies Inc (LOW) , Bausch Health Companies Inc (BHC) have a combined weighting of 2.46% among all his current holdings.

Latest Holdings of Robert Alexander Ingram

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EW Edwards Lifesciences Corp 2014-07-31 183,246 66.69 12,220,676
REGN Regeneron Pharmaceuticals Inc 2015-05-27 1,500 829.43 1,244,145
WOLF Wolfspeed Inc 2015-12-01 48,846 12.87 628,648
BCRX BioCryst Pharmaceuticals Inc 2019-11-18 48,088 7.06 339,261
BDTX Black Diamond Therapeutics Inc 2020-09-30 5,000 3.25 16,250
NOVNQ NVN Liquidation Inc 2019-05-22 16,978 0.00 0
AGN Allergan PLC 2011-02-15 0 193.02 0
LOW Lowe's Companies Inc 2010-05-27 0 269.18 0
BHC Bausch Health Companies Inc 2011-02-28 0 9.69 0

Holding Weightings of Robert Alexander Ingram


Robert Alexander Ingram Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Alexander Ingram has made a total of 0 transactions in Edwards Lifesciences Corp (EW) over the past 5 years. The most-recent trade in Edwards Lifesciences Corp is the sale of 75,000 shares on July 31, 2014, which brought Robert Alexander Ingram around $1 Million.

According to the SEC Form 4 filings, Robert Alexander Ingram has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 1,379 shares on May 27, 2015, which brought Robert Alexander Ingram around $707,965.

According to the SEC Form 4 filings, Robert Alexander Ingram has made a total of 0 transactions in Wolfspeed Inc (WOLF) over the past 5 years. The most-recent trade in Wolfspeed Inc is the sale of 3,750 shares on December 1, 2015, which brought Robert Alexander Ingram around $103,762.

More details on Robert Alexander Ingram's insider transactions can be found in the Insider Trading History of Robert Alexander Ingram table.

Insider Trading History of Robert Alexander Ingram

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Alexander Ingram Trading Performance

GuruFocus tracks the stock performance after each of Robert Alexander Ingram's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Alexander Ingram is 4.34%. GuruFocus also compares Robert Alexander Ingram's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Alexander Ingram within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Alexander Ingram's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Alexander Ingram

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 22.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 22.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert Alexander Ingram Ownership Network

Ownership Network List of Robert Alexander Ingram

No Data

Ownership Network Relation of Robert Alexander Ingram

Insider Network Chart

Robert Alexander Ingram Owned Company Details

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Robert Alexander Ingram is the director of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Robert Alexander Ingram made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

Robert Alexander Ingram Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Alexander Ingram. You might contact Robert Alexander Ingram via mailing address: 280 S. Mangum Street, Suite 350, Durham Nc 27701.